Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Fentanyl 100mcg in 2ml Solution for Injection – PA0073/122/001
- Mivacron 2mg/ml Solution for Injection – PA1691/033/001
- Osteofos D3 1200mg/800IU Powder for Oral Suspension – PA0865/007/001
- Sublimaze 50mcg/ml Solution for Injection – PA0748/044/001
- Zoely 2.5mg/1.5mg Film Coated Tablet – EU/1/11/690/001
The following shortage has been resolved and supply has resumed to the Irish market:
- Duac Once Daily 10mg/g + 50mg/g Gel – PA1077/120/001
- Faverin 100mg Film Coated Tablet – PA2010/031/002
- Fybogel Mebeverine Granules for Oral Suspension – PA0979/010/001
- Imdur 60mg Prolonged Release Tablet – PA2129/001/001
- Letrozole Accord 2.5mg Tablet – PA2315/109/001
- Livial 2.5mg Tablet – PA1286/059/001
- Notiabolfen XL 150mg Prolonged Release Tablet – PA2315/066/005
- Scheriproct 1mg Suppositories – PA1410/071/002
- Tevaquel 25mg Film Coated Tablet – PA0749/060/001
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated in real time.